128 related articles for article (PubMed ID: 30227113)
21. Interleukin-4 and STAT6 promoter polymorphisms but not interleukin-10 or 13 are essential for schistosomiasis and associated disease burden among Nigerian children.
Adedokun SA; Seamans BN; Cox NT; Liou G; Akindele AA; Li Y; Ojurongbe O; Thomas BN
Infect Genet Evol; 2018 Nov; 65():28-34. PubMed ID: 30010060
[TBL] [Abstract][Full Text] [Related]
22. The polymorphisms of IL-4, IL-4R and IL-13 genes and bladder cancer risk in a Chinese population: a case-control study.
Chu H; Ma L; Wang M; Shi D; Qin C; Yuan L; Yin C; Zhang Z
Mol Biol Rep; 2012 May; 39(5):5349-57. PubMed ID: 22170601
[TBL] [Abstract][Full Text] [Related]
23. The lL-8 and IL-13 gene polymorphisms in inflammatory bowel disease and colorectal cancer.
Walczak A; Przybylowska K; Dziki L; Sygut A; Chojnacki C; Chojnacki J; Dziki A; Majsterek I
DNA Cell Biol; 2012 Aug; 31(8):1431-8. PubMed ID: 22741617
[TBL] [Abstract][Full Text] [Related]
24. Promoter polymorphisms in TGFB1 and IL10 genes influence tumor dendritic cells infiltration, development and prognosis of colorectal cancer.
Gulubova M; Aleksandrova E; Vlaykova T
J Gene Med; 2018 Feb; 20(2-3):e3005. PubMed ID: 29388277
[TBL] [Abstract][Full Text] [Related]
25. Association of interleukin-17A polymorphisms with the risk of colorectal cancer: A case-control study.
Bedoui SA; Barbirou M; Stayoussef M; Dallel M; Mokrani A; Makni L; Mezlini A; Bouhaouala B; Yacoubi-Loueslati B; Almawi WY
Cytokine; 2018 Oct; 110():18-23. PubMed ID: 29689450
[TBL] [Abstract][Full Text] [Related]
26. Recurrent aphthous stomatitis and gene variability in selected interleukins: a case-control study.
Borilova Linhartova P; Janos J; Slezakova S; Bartova J; Petanova J; Kuklinek P; Fassmann A; Dusek L; Izakovicova Holla L
Eur J Oral Sci; 2018 Dec; 126(6):485-492. PubMed ID: 30341786
[TBL] [Abstract][Full Text] [Related]
27. Gene Polymorphism of Interleukin-4, Interleukin-4 Receptor and STAT6 in Children with Atopic Dermatitis in Taif, Saudi Arabia.
Hussein YM; Alzahrani SS; Alharthi AA; Alhazmi AS; Ghonaim MM; Alghamdy AA; El Askary A
Immunol Invest; 2016; 45(3):223-34. PubMed ID: 27018548
[TBL] [Abstract][Full Text] [Related]
28. Expression and Polymorphism of TSLP/TSLP Receptors as Potential Diagnostic Markers of Colorectal Cancer Progression.
Semlali A; Almutairi MH; Alamri A; Reddy Parine N; Arafah M; Almadi MA; Aljebreen AM; Alharbi O; Azzam NA; Almutairi R; Alanazi M; Rouabhia M
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573368
[TBL] [Abstract][Full Text] [Related]
29. The correlation between IL-4 polymorphisms and colorectal cancer risk in a population in Northwest China.
Wen X; Xin X; Li J; Qiao L; Liu F; Guo Y; Qu Z; Wang R; Li X
Eur J Cancer Prev; 2020 Mar; 29(2):95-99. PubMed ID: 31876620
[TBL] [Abstract][Full Text] [Related]
30. TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer.
Castro FA; Försti A; Buch S; Kalthoff H; Krauss C; Bauer M; Egberts J; Schniewind B; Broering DC; Schreiber S; Schmitt M; Hampe J; Hemminki K; Schafmayer C
Eur J Cancer; 2011 May; 47(8):1203-10. PubMed ID: 21239167
[TBL] [Abstract][Full Text] [Related]
31. A preliminary study on the association of single nucleotide polymorphisms of interleukin 4 (IL4), IL13, IL4 receptor alpha (IL4Rα) & Toll-like receptor 4 (TLR4) genes with asthma in Indian adults.
Davoodi P; Mahesh PA; Holla AD; Ramachandra NB
Indian J Med Res; 2015 Dec; 142(6):675-80. PubMed ID: 26831416
[TBL] [Abstract][Full Text] [Related]
32. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
Banday MZ; Sameer AS
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
[No Abstract] [Full Text] [Related]
33. Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma.
Scheurer ME; Amirian E; Cao Y; Gilbert MR; Aldape KD; Kornguth DG; El-Zein R; Bondy ML
Clin Cancer Res; 2008 Oct; 14(20):6640-6. PubMed ID: 18927306
[TBL] [Abstract][Full Text] [Related]
34. Association of IL4, IL13, and IL4R polymorphisms with gastrointestinal cancer risk: A meta-analysis.
Cho YA; Kim J
J Epidemiol; 2017 May; 27(5):215-220. PubMed ID: 28142034
[TBL] [Abstract][Full Text] [Related]
35. One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status.
Myte R; Gylling B; Häggström J; Schneede J; Löfgren-Burström A; Huyghe JR; Hallmans G; Meyer K; Johansson I; Ueland PM; Palmqvist R; Van Guelpen B
PLoS One; 2018; 13(4):e0196233. PubMed ID: 29694444
[TBL] [Abstract][Full Text] [Related]
36. Association of cytokine Th2 gene polymorphisms with autoimmune thyroid diseases in Tunisian population.
Mestiri S; Zaaber I; Inoubli O; Abid N; Omrani A; Nejehi H; Marmouch H
Int J Immunogenet; 2020 Jun; 47(3):294-308. PubMed ID: 31900992
[TBL] [Abstract][Full Text] [Related]
37. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
[TBL] [Abstract][Full Text] [Related]
38. Association between IL-4 -589C>T polymorphism and colorectal cancer risk.
Li Q; Wang Q; Xu X; Ren S; Wang L
Tumour Biol; 2014 Mar; 35(3):2675-9. PubMed ID: 24218339
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms and haplotype analysis of IL-4Ralpha Q576R and I75V in patients with penicillin allergy.
Huang CZ; Yang J; Qiao HL; Jia LJ
Eur J Clin Pharmacol; 2009 Sep; 65(9):895-902. PubMed ID: 19421745
[TBL] [Abstract][Full Text] [Related]
40. Interleukin promoter polymorphisms and prognosis in colorectal cancer.
Wilkening S; Tavelin B; Canzian F; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P; Försti A
Carcinogenesis; 2008 Jun; 29(6):1202-6. PubMed ID: 18448485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
